Cardiovascular Diseases Research in Alabama
Cardiovascular Diseases Research (93.837) awarded $235 million to recipients in Alabama in 185 grants from fiscal 2021 to 2025, 1.6% of the program's national total. University of Alabama at Birmingham received the most, $209 million.
- Awarded in Alabama$235 million
- Awards185
- Share of the program1.6%
- Rank among states21st of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 96 | $47.9 million |
| FY 2022 | 99 | $50.1 million |
| FY 2023 | 103 | $49.1 million |
| FY 2024 | 89 | $46.1 million |
| FY 2025 | 87 | $42.2 million |
Recipients in Alabama
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of Alabama at Birmingham | State and local governments | 159 | $209 million |
| University of South Alabama | Colleges and universities | 16 | $18.3 million |
| Auburn University | Colleges and universities | 5 | $3.9 million |
| Alveolus Bio, Inc. | Small businesses | 1 | $2.3 million |
| Endomimetics, Inc. | Small businesses | 2 | $801,425 |
| University of Alabama | Colleges and universities | 1 | $458,873 |
| Oakwood University, Inc. | Colleges and universities | 1 | $385,033 |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 82 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to Alabama?
$235 million from fiscal 2021 to 2025, across 185 awards. Alabama ranks 21st of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in Alabama?
The largest recipient is University of Alabama at Birmingham, with $209 million in 159 awards. Next are University of South Alabama and Auburn University.
Can organizations in Alabama apply now?
Yes, 82 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in Alabama
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Children's Health Insurance Program
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Broadband Equity, Access, and Deployment Program
- Special Education Grants to States
- Head Start